HOME Research Insight Key Players in the Allergy Diagnostics Market Focus on New Product Launches, Expansions, Acquisitions, and Partnerships

Key Players in the Allergy Diagnostics Market Focus on New Product Launches, Expansions, Acquisitions, and Partnerships

The allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. High incidence and large economic burden of allergic diseases, growing demand for allergy diagnosis, increasing healthcare expenditure, and technological advancements are driving the growth of this market.

The allergy diagnostics market is consolidated in nature due to the presence of a large number of players. The key players in the market are Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), and Tecan Trading AG (Switzerland).

The key strategy followed by most companies in the allergy diagnostics market are product launches. This strategy accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players that adopted this strategy include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), bioMérieux SA (France), Omega Diagnostics Group PLC (UK), INDOOR Biotechnologies, Inc. (US), and DR. FOOKE - Achterrath Laboratorien GmbH (Germany).

Thermo Fisher Scientific Inc. (US) accounted for the largest market share of the allergy diagnostics market in 2016. The company caters to the allergy diagnostics market through its Clinical & Diagnostics product segment. The end users that the company caters to are pharmaceutical and biotechnology companies, hospitals and clinical diagnostic laboratories, universities, research institutions, government agencies, and environmental & process control industries. Thermo Fisher offers a broad range of products covering all segments of the allergy diagnostics market. The company launched innovative products for allergy diagnosis over the last three years in all categories, namely, assay kits and instruments. Thermo Fisher used product innovation as the main strategy to maintain its competitive position in the market. For example, the company launched Thermo Scientific B·R·A·H·M·S Procalcitonin (PCT) assay for allergy diagnosis in 2016.

Siemens AG (Germany) held the second largest share of the global allergy diagnostics market. The company has a strong presence in the US, Europe, and Asia Pacific. Siemens AG focuses on new product launches as its key strategy. In July 2014, Siemens Healthineers launched its latest ADVIA Centaur XPT Immunoassay System1, ADVIA Chemistry XPT System, and Precia Stride Coagulation Analyzer products at the IFCC World Lab in Istanbul.

Related Reports:

Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022

Mr. Rohan
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports